164 related articles for article (PubMed ID: 3874450)
21. HLA family studies and multiple sclerosis: A common gene, dominantly expressed.
Stewart GJ; McLeod JG; Basten A; Bashir HV
Hum Immunol; 1981 Aug; 3(1):13-29. PubMed ID: 7275697
[TBL] [Abstract][Full Text] [Related]
22. Multiple sclerosis in north-east Scotland. An association with HLA-DQw1.
Francis DA; Batchelor JR; McDonald WI; Hing SN; Dodi IA; Fielder AH; Hern JE; Downie AW
Brain; 1987 Feb; 110 ( Pt 1)():181-96. PubMed ID: 3492235
[TBL] [Abstract][Full Text] [Related]
23. HLA and multiple sclerosis in south east Wales.
Swingler RJ; Kirk PF; Darke C; Compston DA
J Neurol Neurosurg Psychiatry; 1987 Sep; 50(9):1153-5. PubMed ID: 3499485
[TBL] [Abstract][Full Text] [Related]
24. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.
Rubio JP; Bahlo M; Stankovich J; Burfoot RK; Johnson LJ; Huxtable S; Butzkueven H; Lin L; Taylor BV; Speed TP; Kilpatrick TJ; Mignot E; Foote SJ
Immunogenetics; 2007 Mar; 59(3):177-86. PubMed ID: 17256150
[TBL] [Abstract][Full Text] [Related]
25. Family studies in multiple sclerosis: HLA haplotypes of affected sib-pairs.
Mayer-Rienecker HJ; Wegener S; Hitzschke B
Eur Arch Psychiatry Neurol Sci; 1984; 234(1):5-7. PubMed ID: 6489396
[TBL] [Abstract][Full Text] [Related]
26. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group.
Haines JL; Terwedow HA; Burgess K; Pericak-Vance MA; Rimmler JB; Martin ER; Oksenberg JR; Lincoln R; Zhang DY; Banatao DR; Gatto N; Goodkin DE; Hauser SL
Hum Mol Genet; 1998 Aug; 7(8):1229-34. PubMed ID: 9668163
[TBL] [Abstract][Full Text] [Related]
27. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
28. HLA genetic determinants in familial MS. A study from the Grampian region of Scotland.
Francis DA; Batchelor JR; McDonald WI; Dodi IA; Hing SN; Hern JE; Downie AW
Tissue Antigens; 1987 Jan; 29(1):7-12. PubMed ID: 3590146
[TBL] [Abstract][Full Text] [Related]
29. Multiple sclerosis in the Faroe Islands. VI. Studies of HLA markers.
Jersild C; Kurtzke JF; Riisom K; Heltberg A; Arbuckle J; Hyllested K
Tissue Antigens; 1993 Aug; 42(2):105-10. PubMed ID: 7903488
[TBL] [Abstract][Full Text] [Related]
30. HLA determinants of susceptibility to multiple sclerosis in an Arabian Gulf population.
Al-Shammri S; Nelson RF; Al-Muzairi I; Akanji AO
Mult Scler; 2004 Aug; 10(4):381-6. PubMed ID: 15327033
[TBL] [Abstract][Full Text] [Related]
31. Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity.
Salier JP; Sesboüé R; Martin-Mondière C; Daveau M; Cesaro P; Cavelier B; Coquerel A; Legrand L; Goust JM; Degos JD
J Clin Invest; 1986 Aug; 78(2):533-8. PubMed ID: 3461005
[TBL] [Abstract][Full Text] [Related]
32. Extended major histocompatibility complex haplotypes in patients with multiple sclerosis.
Hauser SL; Fleischnick E; Weiner HL; Marcus D; Awdeh Z; Yunis EJ; Alper CA
Neurology; 1989 Feb; 39(2 Pt 1):275-7. PubMed ID: 2783768
[TBL] [Abstract][Full Text] [Related]
33. Multiple sclerosis immunopathic trait and HLA-DR(2)15 as independent risk factors in multiple sclerosis.
Callander M; Haghighi S; Landtblom AM; Ahlgren CE; Nilsson SI; Rydberg L; Al Khoury H; Rosegren L; Andersen O
Mult Scler; 2007 May; 13(4):441-5. PubMed ID: 17463066
[TBL] [Abstract][Full Text] [Related]
34. Association between HLA B7, DR2 and dysfunction of natural- and antibody-mediated cytotoxicity without connection with the deficient interferon production in multiple sclerosis.
Gyódi E; Benczur M; Pálffy G; Tálas M; Petrányi G; Földes I; Hollán SR
Hum Immunol; 1982 Jun; 4(3):209-17. PubMed ID: 6181031
[TBL] [Abstract][Full Text] [Related]
35. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel.
Karni A; Kohn Y; Safirman C; Abramsky O; Barcellos L; Oksenberg JR; Kahana E; Karussis D; Chapman J; Brautbar C
Mult Scler; 1999 Dec; 5(6):410-5. PubMed ID: 10618697
[TBL] [Abstract][Full Text] [Related]
36. Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.
Zipp F; Weber F; Huber S; Sotgiu S; Czlonkowska A; Holler E; Albert E; Weiss EH; Wekerle H; Hohlfeld R
Ann Neurol; 1995 Nov; 38(5):723-30. PubMed ID: 7486863
[TBL] [Abstract][Full Text] [Related]
37. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
Krogsgaard M; Wucherpfennig KW; Cannella B; Hansen BE; Svejgaard A; Pyrdol J; Ditzel H; Raine C; Engberg J; Fugger L
J Exp Med; 2000 Apr; 191(8):1395-412. PubMed ID: 10770805
[TBL] [Abstract][Full Text] [Related]
38. Distribution of HLA-SB antigens in multiple sclerosis.
Moen T; Stien R; Bratlie A; Bondevik E
Tissue Antigens; 1984 Aug; 24(2):126-7. PubMed ID: 6593898
[No Abstract] [Full Text] [Related]
39. HLA antigens in multiple sclerosis in coloured South Africans.
Fewster ME; Kies B
J Neurol Sci; 1984; 66(2-3):175-81. PubMed ID: 6597862
[TBL] [Abstract][Full Text] [Related]
40. Viral infection in patients with multiple sclerosis and HLA-DR matched controls.
Compston DA; Vakarelis BN; Paul E; McDonald WI; Batchelor JR; Mims CA
Brain; 1986 Apr; 109 ( Pt 2)(2):325-44. PubMed ID: 3456817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
